by Matthias Burel | Jan 12, 2022 | News
Corsano Health Receives FDA Clearance Corsano Health is announcing that its CardioWatch 287-2 System received FDA Clearance. The Hague, March 22, 2024 – Corsano Health, a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient...
by Matthias Burel | Jan 10, 2022 | News
Corsano Health Winner at HIMSS! We are thrilled to announce that our CEO Peter Stas presented Corsano Health's innovative CardioWatch solution at HIMSS24 Startup Competition in Rome. This prestigious event showcases groundbreaking health tech and we are honored to...
by Matthias Burel | Jan 9, 2022 | News
Corsano cooperates now with Roche Diagnostics Corsano launched commercialization of its CardioWatch EU-MDR certified patient monitoring bracelet on cobas® pulse, a digitally enabled professional blood glucose management solution from Roche. CardioWatch 287-2 together...
by Matthias Burel | Jan 8, 2022 | News
Corsano Health Joins SEARCH The Synthetic hEalthcare dAta goveRnanCe Hub (SEARCH) aims to accelerate healthcare innovation by generating FAIRified synthetic data for use in AI/ML models Today Tuesday, 1st October 2024 sees the launch of the Synthetic hEalthcare dAta...
by Matthias Burel | Jan 7, 2022 | News
Corsano EndoWatch; the smart device that helps patients with hormonal imbalance after treatment for a brain tumor. Research Summary Children and adolescents with hypothalamic brain tumors often have excellent survival, but poor outcome due to hypothalamic dysfunction...
